|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1994-1-10
|
|
pubmed:abstractText |
Short-term, high dose growth hormone (GH) treatment has been advocated in many catabolic disease states. It is likely that some of the anabolic effects of GH are mediated through activation of lipolysis, but the metabolic impact of therapeutically relevant GH exposure is not known in detail. The present study was accordingly designed to assess the effects of such GH exposure on basal and insulin stimulated intermediary metabolism.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0300-0664
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
577-81
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8252748-Adult,
pubmed-meshheading:8252748-Basal Metabolism,
pubmed-meshheading:8252748-Blood Glucose,
pubmed-meshheading:8252748-Drug Administration Schedule,
pubmed-meshheading:8252748-Energy Metabolism,
pubmed-meshheading:8252748-Fatty Acids, Nonesterified,
pubmed-meshheading:8252748-Female,
pubmed-meshheading:8252748-Growth Hormone,
pubmed-meshheading:8252748-Humans,
pubmed-meshheading:8252748-Insulin,
pubmed-meshheading:8252748-Insulin-Like Growth Factor I
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Impact of 2 weeks high dose growth hormone treatment on basal and insulin stimulated substrate metabolism in humans.
|
|
pubmed:affiliation |
University Department of Internal Medicine, (Endocrinology and Diabetes), Aarhus Kommunehospital, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
